The Ministry of Health in Mexico has reported an additional four cases of infection with Vibrio cholerae O1 Ogawa. Of these, three are from the state of Veracruz and one from the state of Hidalgo.
Since the beginning of this outbreak in September 2013 to date, a total of 184 confirmed cases, including one death, of cholera due to Vibrio cholerae O1 Ogawa has been reported in the country. Of these, 160 cases from the state of Hidalgo, 11 from the state of Veracruz, nine from the state of Mexico, two are from the Federal District, and two from the state of San Luis Potosi.
The health authorities of Mexico continue to strengthen surveillance and to ensure the availability and quality of care in medical units.
Measures are being implemented to ensure access to drinking water and basic sanitation at the community level. Awareness campaigns, particularly around safe water and food consumption are being carried out in Spanish and indigenous languages. Health professionals at different levels of the healthcare system are being trained in prevention and treatment of the disease.
An antimicrobial susceptibility test for Vibrio cholerae O1 Ogawa was conducted by the Institute of Epidemiological Diagnostics and Reference (InDRE) which demonstrated that the bacterium was susceptible to doxycycline and chloramphenicol, with reduced susceptibility to ciprofloxacin and resistance to trimethoprim/sulfamethoxazole.
This is the first local transmission of cholera recorded since 2001 in Mexico. The genetic profile of the bacterium obtained from patients in Mexico presents high similarity (95 percent) with the strain that is currently circulating in three Caribbean countries (Haiti, Dominican Republic and Cuba), and is different from the strain that had been circulating in Mexico during 1991-2001.
The World Health Organization (WHO) does not recommend that any travel or trade restrictions be applied to Mexico with respect to this event.
Source: WHO
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.